Description
Antisense oligonucleotides, delivered into cells with cationic lipids, are standard tools for the elucidation of gene function (1,2). However, there are two main problems associated with lipid-mediated delivery of antisense oligonucleotides: poor transfection efficiency and/or high levels of cytotoxicity. Cytofectin™ Transfection Reagent alleviates both of these problems, delivering oligonucleotides efficiently into a broad spectrum of cell lines. Cytofectin Transfection Reagent corresponds to Gilead Sciences' GS 3815 which is a more stable formulation of GS 2888, first reported by Lewis, et al. (3).
| Cell Line |
Species |
Type |
| COS-7 |
Monkey |
Kidney |
| CV-1 |
Monkey |
Kidney |
| BalbC-3T3 |
Mouse |
Embryo fibroblast |
| Rat-2 |
Rat |
Embryo |
| HeLa |
Human |
Cervical carcinoma |
| NHDF |
Human |
Dermal fibroblast |
| MCF-7 |
Human |
Breast carcinoma |
| A549 |
Human |
Lung carcinoma |
| T24 |
Human |
Bladder carcinoma |
| HCT116 |
Human |
Colon carcinoma |
| H460 |
Human |
Lung carcinoma |
| WiDR |
Human |
Colon carcinoma |
| HT-29 |
Human |
Colon carcinoma |
| CasKi |
Human |
Cervical carcinoma |
| SiHa |
Human |
Cervical carcinoma |

Contents
Cytofectin™ Reagent Lipid (1 x 1 ml for Cat. No. T610001 or 5 x 1 ml for
Cat. No. T610005)
Storage
The Cytofectin™ Transfection Reagent is shipped on ice. Store all reagents
at 4ºC upon receipt. If stored properly, all components are stable for 3 months.
For longer term stability store at -70ºC.
References:
1. Wagner, RW et al. (1994) Nature 372: 333-335.
2. Wagner, RW et al. (1993) Science 260: 1510-1513.
3. Lewis, JG et al (1996) Proc. Natl. Acad. U.S.A. 93: 3176-3181.
4. Axel, DI et al. (2000) J Vasc Res. 37(4): 221-234.